01/06/2026
#ΒοτουλινικήΤοξίνη και η έννοια του στην διαχείριση της #ΑυχενικήςΔυστονίας.
Εξαιρετική εισήγηση για την #ΗμέραΔυστονίας2026 με εστίαση στην ανάγκη υπερηχογραφικής καθοδήγησης της έγχυσης!
Η ημερίδα: https://www.youtube.com/live/n-nM5G4Ygm4?is=tTQISOdzmrgkv7lO
Botulinum neurotoxin (BoNT) remains the cornerstone treatment for focal dystonias, yet therapeutic outcomes depend heavily on precise targeting, individualised goal setting, and attention to the full clinical spectrum of the disorder.
In his presentation today, Prof Bo Biering-Sørensen reviewed the mechanism of action of and outlined strategies for optimising treatment, with particular emphasis on ultrasound‑guided injections and the COL‑CAP concept as key tools for enhancing accuracy and efficacy in cervical dystonia.
Because extends beyond motor manifestations, the often under-recognised non‑motor symptoms- such as pain, fatigue, anxiety, and sleep disturbances- were also highlighted as essential contributors to disability and quality‑of‑life outcomes.
Integrating structured, patient‑centered goal setting into clinical practice ensures that BoNT interventions align with what is most meaningful to the individual patient. This approach naturally underscores the importance of effective patient–physician communication, enabling collaborative decision‑making, enhancing satisfaction, and ultimately improving long‑term treatment success.
Our conference continues here in Malmo, and can be viewed live on the Dystonia Europe YouTube channel at https://www.youtube.com/watch?v=n-nM5G4Ygm4
